While EGFR mutations in non-small cell lung cancer were by far the most common and statistically significant in this population (n = 1630), we also found significant associations with small cell lung cancer, prostate cancer, kidney cancer, thyroid cancer, and the heterogeneous group of unknown primary cancers. The gene discussed is EGFR; the disease is thyroid gland carcinoma.